Review
Open access
Sep 2026
The HIF-1α–Mitochondria Axis in Alzheimer's Disease: Therapeutic Potential of Roxadustat in Restoring Neuronal Bioenergetics and Cognitive Function
Although direct evidence in AD remains limited, targeting HIF-1α-mediated mitochondrial adaptation represents a promising approach that may complement existing therapies and warrants further preclinical and clinical investigation.
R. Elavarasi, P. A, V. R et al.
· International journal of che... · 0 citations